Cancellation of state registration. Fancidar®

February 06, 2018
Trade names:
ICD-10:
I.B50-B64.B50    Malaria caused by Plasmodium falciparum
I.B50-B64.B52    Malaria caused by Plasmodium malariae
I.B50-B64.B51    Malaria caused by Plasmodium vivax
I.B50-B64.B58    Toxoplasmosis
I.B50-B64.B59    Pneumocystis
Fundishar, malaria, treatment of malaria, toxoplasmosis, treatment of toxoplasmosis, pneumocystis, pneumocystis infection

The Ministry of Health of the Russian Federation in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines" decided toabolishment of state registration and exclusion from the state register of medicinal products for the medical use of the medicinal product (registration certificate No. N014161 / 01 of 06.10.2008 issued by F. Hoffmann-La Roche, Ltd.):

Fancidar® (trade name of the medicinal product)

Sulphadoxine + Pyrimethamine (international non-proprietary or grouping or chemical name)

tablets, 500 mg / 25 mg (dosage form, dosage)

F.Hoffmann-La Roche Ltd, Switzerland Grenzacherstrasse 124, 4070 Basel, Switzerland (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by the authorized legal entity Representative Office "F.Hoffmann-La Roche Ltd." applications for the abolition of state registration of a medicinal product.